🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 11 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/08/2015 | 59,20 | 59,76 | 54,04 | 54,10 | -9,55% | 9,66% | 731.770 |
| 19/08/2015 | 59,51 | 60,80 | 58,88 | 59,82 | -0,32% | 3,23% | 471.923 |
| 18/08/2015 | 60,51 | 61,38 | 59,15 | 60,01 | -1,41% | 3,70% | 514.403 |
| 17/08/2015 | 58,01 | 60,90 | 57,52 | 60,87 | +3,99% | 5,83% | 396.743 |
| 14/08/2015 | 58,51 | 59,81 | 56,91 | 58,54 | +0,20% | 4,96% | 405.880 |
| 13/08/2015 | 60,31 | 61,32 | 58,16 | 58,42 | -2,45% | 5,24% | 629.979 |
| 12/08/2015 | 57,39 | 60,38 | 56,83 | 59,89 | +2,55% | 6,19% | 569.386 |
| 11/08/2015 | 58,88 | 59,90 | 57,34 | 58,40 | -2,27% | 4,34% | 642.162 |
| 10/08/2015 | 58,63 | 60,82 | 58,63 | 59,75 | +1,75% | 3,72% | 765.913 |
| 07/08/2015 | 64,89 | 65,19 | 57,20 | 58,72 | -10,00% | 12,31% | 1.654.617 |
| 06/08/2015 | 69,25 | 69,87 | 63,92 | 65,25 | -5,99% | 8,58% | 1.127.550 |
| 05/08/2015 | 67,47 | 70,12 | 67,40 | 69,40 | +1,77% | 4,03% | 697.145 |
| 04/08/2015 | 68,13 | 68,44 | 67,16 | 68,19 | +0,52% | 1,88% | 414.696 |
| 03/08/2015 | 67,76 | 67,97 | 67,31 | 67,84 | +0,44% | 0,98% | 401.872 |
| 31/07/2015 | 67,40 | 68,36 | 66,54 | 67,54 | +0,45% | 2,69% | 549.188 |
| 30/07/2015 | 66,78 | 68,59 | 64,37 | 67,24 | +0,86% | 6,31% | 542.936 |
| 29/07/2015 | 66,43 | 67,00 | 63,64 | 66,66 | +0,96% | 5,05% | 449.962 |
| 28/07/2015 | 64,25 | 66,69 | 63,34 | 66,03 | +3,21% | 5,21% | 366.927 |
| 27/07/2015 | 63,16 | 64,93 | 62,40 | 63,97 | +0,45% | 4,01% | 419.024 |
| 24/07/2015 | 65,19 | 66,39 | 63,42 | 63,69 | -2,45% | 4,55% | 342.882 |
| 23/07/2015 | 66,39 | 67,19 | 65,03 | 65,28 | -1,55% | 3,25% | 416.620 |
| 22/07/2015 | 64,39 | 66,38 | 63,94 | 66,31 | +1,87% | 3,79% | 408.124 |
| 21/07/2015 | 65,98 | 66,24 | 63,06 | 65,10 | -1,16% | 4,82% | 509.914 |
| 20/07/2015 | 65,93 | 66,08 | 64,54 | 65,86 | +0,04% | 2,35% | 567.622 |
| 17/07/2015 | 65,96 | 66,68 | 65,12 | 65,83 | +0,20% | 2,36% | 301.524 |
| 16/07/2015 | 64,78 | 66,41 | 64,30 | 65,70 | +1,95% | 3,26% | 436.016 |
| 15/07/2015 | 65,53 | 65,61 | 64,10 | 64,45 | -0,79% | 2,29% | 552.714 |
| 14/07/2015 | 64,03 | 66,34 | 63,79 | 64,96 | +1,61% | 3,98% | 932.145 |
| 13/07/2015 | 62,83 | 64,09 | 62,82 | 63,93 | +2,77% | 2,02% | 445.794 |
| 10/07/2015 | 62,50 | 62,54 | 60,88 | 62,21 | +0,46% | 2,65% | 442.749 |